Related Experiment Video
Updated: Aug 20, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colorectal carcinoma in children, adolescents, and young adults
Guillermo L Chantada1, Viviana B Perelli, Mercedes García Lombardi
1Hospital J. P. Garrahan, Buenos Aires, Argentina.
Insights
Colorectal carcinoma in patients under 30 presents with advanced disease and poorer prognosis, particularly in those under 20. Early diagnosis is crucial for improving outcomes in young colorectal cancer patients.
Area of Science:
- Oncology
- Gastroenterology
- Pediatric Oncology
Background:
- Colorectal carcinoma (CRC) is increasingly diagnosed in young adults.
- Understanding prognostic factors in pediatric and young adult CRC is essential.
Observation:
- A retrospective study evaluated 21 patients under 30 with CRC in Argentina.
- Patients were stratified into two groups: 0-20 years (pediatric centers, n=14) and 21-30 years (adult centers, n=7).
Findings:
- The younger group (0-20 years) presented with significantly more advanced disease.
- Patients under 20 experienced a poorer prognosis compared to those aged 21-30.
- Disease-free survival was observed in 6 patients; 13 died of progressive disease.
Implications:
- Younger age at diagnosis, especially under 20, is associated with worse outcomes in colorectal cancer.
- Advanced disease at presentation is a likely contributor to the poorer prognosis in this cohort.
- Further research into early detection and tailored treatment strategies for pediatric and young adult CRC is warranted.
Abstract:
The authors conducted a retrospective evaluation of patients younger than 30 years with colorectal carcinoma in Argentina. Patients were divided into group 1 (patients treated at pediatric institutions from 0 to 20 years of age, n = 14) and group 2 (patients from 21 to 30, n = 7, treated at adult centers). Group 1 had significantly more advanced disease and a poorer prognosis. Six patients (2/14 in group 1 and 4/7 in group 2) survive disease-free. Thirteen patients died of progressive disease, 1 died of a non-tumor-related cause, and 1 is still on treatment. Patients younger than 20 years have a poorer prognosis, probably because of advanced disease on presentation.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Treatment Resistent Cancers
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Treatment Resistant Cancers